Hepatocellular carcinoma
Conditions
Interventions
Observation group:Basic treatment + Transcutaneous Electrical Acupoint Stimulation
Control group:Basic treatment + placebo Transcutaneous Electrical Acupoint Stimulation
Sponsors
Yueyang Integrated Traditional Chinese and Western Medicine Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
50 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Patients meeting the diagnostic criteria for Hepatocellular carcinoma; (2) Age =50 and =80 years old gender not limited; (3) The NRS score within 24 hours before screening is =4 points; (4) Patients with Child-Pugh grade A or B; (5) Patients with an expected survival period > 3 months; (6) Clear consciousness capable of assessing one's own pain and quality of life; (7) Those who understand and agree to participate in this study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Patients with other physical or pathological pains; (2) Patients who have undergone tumor resection within the past 3 to 6 months; (3) Patients with severe complications such as persistent ascites abdominal cavity infection gastrointestinal bleeding liver failure and abdominal cavity hemorrhage; (4) Suffer from severe acute or chronic organic diseases or mental disorders; (5) Patients with contraindications to transcutaneous acupoint electrical stimulation such as those with local skin damage those who are particularly sensitive to electric current those with pacemakers or cardiovascular stents; (6) Patients who have previously received percutaneous electrical acupoint stimulation; (7) Patients who are scheduled to undergo surgery within the last two months. If any of the above conditions is met it will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Opioid drug tolerance index; | — |
Secondary
| Measure | Time frame |
|---|---|
| The number of breakouts of pain;Proteomics analysis;Assessment of quality of life;Assessment of pain degree;The frequency of gastrointestinal side effects; | — |
Countries
China
Contacts
Public ContactZHU LU
Shanghai acupuncture and moxibustion Meridian Research Institute
Outcome results
None listed